Medical treatment of essential tremor and Parkinson's disease
- PMID: 9597979
Medical treatment of essential tremor and Parkinson's disease
Abstract
Although there is no known cure for essential tremor or Parkinson's disease (PD), medical treatment can often significantly reduce or eliminate functional disability. Mild essential tremor does not require treatment, and early treatment does not arrest or slow the natural progression in symptoms. When essential tremor interferes with daily activities, medical treatment options include beta blockers, anticonvulsants, benzodiazepines, and carbonic anhydrase inhibitors. Because of the great variability in the presentation of PD, no single approach is appropriate for all patients. Levodopa is the mainstay of pharmacologic therapy for PD, although other agents are indicated for monotherapy or in combination with levodopa. These include traditional and newer dopamine agonists, amantadine, anticholinergics, selegiline, and an emerging class of agents called COMT inhibitors.
Similar articles
-
Treatment options for early Parkinson's disease.Am Fam Physician. 1996 Mar;53(4):1281-7. Am Fam Physician. 1996. PMID: 8629572 Review.
-
[Initial treatment of Parkinson's disease].Rev Neurol. 1997 Aug;25 Suppl 2:S163-9. Rev Neurol. 1997. PMID: 9280684 Review. Spanish.
-
[Pharmacological treatment of parkinsonian tremor].Nihon Rinsho. 2000 Oct;58(10):2091-5. Nihon Rinsho. 2000. PMID: 11068452 Review. Japanese.
-
[Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].MMW Fortschr Med. 2007 May 21;149 Suppl 2:94-6. MMW Fortschr Med. 2007. PMID: 17724978 Review. German.
-
Parkinson's disease: managing symptoms and preserving function.Geriatrics. 1995 Sep;50(9):24-31. Geriatrics. 1995. PMID: 7672615 Review.
Cited by
-
Characterization of Carbonic Anhydrase In Vivo Using Magnetic Resonance Spectroscopy.Int J Mol Sci. 2020 Apr 1;21(7):2442. doi: 10.3390/ijms21072442. Int J Mol Sci. 2020. PMID: 32244610 Free PMC article. Review.
-
Beta-blocker therapy for tremor in Parkinson's disease.Cochrane Database Syst Rev. 2003;2003(1):CD003361. doi: 10.1002/14651858.CD003361. Cochrane Database Syst Rev. 2003. PMID: 12535472 Free PMC article.
-
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.Trends Pharmacol Sci. 2011 Apr;32(4):227-34. doi: 10.1016/j.tips.2011.02.010. Epub 2011 Mar 21. Trends Pharmacol Sci. 2011. PMID: 21429598 Free PMC article. Review.
-
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.Br J Pharmacol. 2005 Feb;144(3):317-22. doi: 10.1038/sj.bjp.0706048. Br J Pharmacol. 2005. PMID: 15655528 Free PMC article.
-
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.FASEB J. 2011 Dec;25(12):4486-97. doi: 10.1096/fj.11-192435. Epub 2011 Aug 24. FASEB J. 2011. PMID: 21865315 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous